NOT KNOWN DETAILS ABOUT POLO188

Abstract Multi-injection pharmaceutical goods such as insulin must be formulated to circumvent aggregation and microbial contamination. Tiny-molecule preservatives and nonionic surfactants including poloxamer 188 (P188) are Consequently typically used in protein drug formulations. On the other hand, mixtures of preservatives and surfactants can ind